Abstract
Response to: Lammers RJM, Witjes JA. Developments in intravesical therapy for non-muscle-invasive bladder cancer. Expert Rev. Anticancer Ther. 10(12), 1903–1916 (2010).
Financial & competing interests disclosure
Gary D Steinberg discloses conflicts of interest with Abbott, Adolor, Bioniche, Covidien, Endo Pharmaceuticals, GE Healthcare, Spectrum/Allergan and Tengion. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Editorial assistance, including medical writing, was provided by Nicole Strangman (PhD) and Kris Schuler (MS) of Complete Healthcare Communications, Inc., and was funded by Endo Pharmaceuticals Inc.